Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Form SC 13G/A Apellis Pharmaceuticals, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A GoDaddy Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A agilon health, inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Perella Weinberg Partner Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Holding(s) in Company
-
Holding(s) in Company
-
MBX Biosciences to Participate in Morgan Stanley Global Healthcare Conference
-
Holding(s) in Company
-
Cross River Partners with Current to Further Its Mission of Financial Inclusion and Serving the Underbanked Population of 26 Million
-
FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition
-
Vanguard to Expand Active Lineup with International Dividend Growth Fund
-
Form 13F-HR WELLINGTON MANAGEMENT For: Jun 30
-
US asset manager Thornburg loses outbound investment licence in China
-
Trove Secures $30M Series E Funding Further Expanding Market Leadership Position In Branded Resale and Trade-In
-
Form SC 13G/A CarGurus, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A BANC OF CALIFORNIA, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A F5, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Olo Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A MVB FINANCIAL CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Lumentum Holdings Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
MBX Biosciences Announces U.S. FDA Clearance of IND Application for MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
-
Megan Pelletier Promoted to Executive Vice President, Chief Operations & People Officer of HomeTrust Bank
-
KKR Leads US$190 million Series C Round in Leading Korean Online Platform MUSINSA
-
BetterUp Partners with Microsoft Viva to Drive Peak Performance and Well-Being for Millions in the Workplace
-
FalconX and CF Benchmarks Partner to Create Institutional-Grade Derivatives Contracts
-
Wellington in talks to invest in Kim Kardashian's Skims at $4 billion valuation-sources
-
Orennia Raises US$25 Million in Series B Financing to Expand Cutting-Edge Energy Transition Analytics Platform
-
Form SC 13G/A UNITED THERAPEUTICS Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Wingstop Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Sage Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
MBX Biosciences Appoints Steven J. Prestrelski, Ph.D., M.B.A., as Chief Scientific Officer
-
NewEdge Wealth Adds to Growing Miami Office With Former Wellington Management Equity Portfolio Manager
-
JOHN HANCOCK HEDGED EQUITY & INCOME FUND ANNOUNCES AMENDMENT TO MANAGED DISTRIBUTION PLAN AND DECLARES DECREASED QUARTERLY DISTRIBUTION
-
JOHN HANCOCK HEDGED EQUITY & INCOME FUND REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
-
Aeglea BioTherapeutics (AGLE) Acquires Spyre Therapeutics
-
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
-
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
-
EXL (EXLS) Appoints Sarah Williamson to its Board
-
Sarah Williamson appointed to the EXL Board of Directors
-
Wellington Management Closes Fourth Late-Stage Private Fund, Exceeding $2.5 Billion Target
-
Exclusive-Cloud banking vendor nCino explores sale -sources
-
Hartford Funds Announces the Closure and Liquidation of the Hartford Schroders ESG US Equity ETF
-
Form SC 13G/A Syneos Health, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A VERACYTE, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Nuvei Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A NanoString Technologies Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
BetterUp Now Available on SAPĀ® Store
-
Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
-
Alkeus Announces $150 Million Series B Financing, Supporting Rapid Registration Path for gildeuretinol (ALK-001) in the Treatment of Stargardt Disease
-
Investors who showed Q1 bets on Nvidia may have got boost as it joined $1 trillion club

